Reports for SITAGLIPTIN

Ingredient

SITAGLIPTIN

Shortage reports
Brand name Strength Dosage Status Date Created Date Updated Reports
APO-SITAGLIPTIN/METFORMIN XR 1000MG 50MG TABLET (EXTENDED-RELEASE) Resolved 2023-03-02 2024-02-02 185976
APO-SITAGLIPTIN/METFORMIN XR 1000MG 50MG TABLET (EXTENDED-RELEASE) Resolved 2023-03-02 2024-02-02 185982
APO-SITAGLIPTIN/METFORMIN XR 1000MG 100MG TABLET (EXTENDED-RELEASE) Resolved 2023-03-02 2024-02-02 185967
APO-SITAGLIPTIN/METFORMIN XR 1000MG 100MG TABLET (EXTENDED-RELEASE) Resolved 2023-03-02 2024-02-02 185985
APO-SITAGLIPTIN/METFORMIN XR 500MG 50MG TABLET (EXTENDED-RELEASE) Resolved 2023-03-02 2024-02-02 185970
AURO-SITAGLIPTIN 100MG TABLET Resolved 2023-12-29 2024-02-14 214583
AURO-SITAGLIPTIN 100MG TABLET Resolved 2023-07-24 2023-09-14 199880
AURO-SITAGLIPTIN 50MG TABLET Resolved 2024-11-14 2025-01-31 242981
AURO-SITAGLIPTIN 50MG TABLET Resolved 2024-01-29 2024-07-17 217667
AURO-SITAGLIPTIN 50MG TABLET Resolved 2023-07-24 2023-08-29 199883

Showing 31 to 40 of 78

Discontinuation reports
Brand name Strength Dosage Status Date Created Date Updated Reports
JANUMET 850MG 50MG TABLET To be discontinued 2024-12-12 2024-12-13 245516
STEGLUJAN 5MG 100MG TABLET Discontinued 2021-02-04 2021-02-04 133310
STEGLUJAN 15MG 100MG TABLET Discontinued 2021-02-04 2021-02-04 133307

Showing 1 to 3 of 3